The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126361402 12636140 2 F 20160809 20160809 20160816 EXP US-ACTELION-A-US2016-140467 ACTELION 71.00 YR E M Y 0.00000 20160816 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126361402 12636140 1 PS VENTAVIS ILOPROST 1 Respiratory (inhalation) 5 MCG, 6-8X/DAY MA02DL0 21779 5 UG INHALATION VAPOUR, SOLUTION
126361402 12636140 2 C OPSUMIT MACITENTAN 1 Oral UNK U U 204410 TABLET
126361402 12636140 3 C RIOCIGUAT RIOCIGUAT 1 U 0
126361402 12636140 4 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 1 PUFF, BID U 0 BID
126361402 12636140 5 C ALBUTEROL. ALBUTEROL 1 U 0
126361402 12636140 6 C ATORVASTATIN ATORVASTATIN 1 40 MG, QD U 0 40 MG QD
126361402 12636140 7 C CLOPIDOGREL CLOPIDOGREL BISULFATE 1 75 MG, QD U 0 75 MG QD
126361402 12636140 8 C FUROSEMIDE. FUROSEMIDE 1 20 MG, QD U 0 20 MG QD
126361402 12636140 9 C GLIMEPIRIDE. GLIMEPIRIDE 1 U 0
126361402 12636140 10 C HYDROCODONE BITARTRATE AND ACETAMINOPHEN ACETAMINOPHENHYDROCODONE BITARTRATE 1 Oral 10/325, TID PRN PAIN U 0 TID
126361402 12636140 11 C MUCINEX GUAIFENESIN 1 U 0
126361402 12636140 12 C NASONEX MOMETASONE FUROATE 1 U 0
126361402 12636140 13 C PREDNISONE. PREDNISONE 1 20 MG, QD U 0 20 MG QD
126361402 12636140 14 C PROAIR HFA ALBUTEROL SULFATE 1 U 0
126361402 12636140 15 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 10 MG, QD U 0 10 MG QD
126361402 12636140 16 C SALINE SODIUM CHLORIDE 1 U 0
126361402 12636140 17 C OXYGEN. OXYGEN 1 U 0
126361402 12636140 18 C FISH OIL FISH OIL 1 U 0
126361402 12636140 19 C SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 1 PUFF, BID U 0 BID
126361402 12636140 20 C POTASSIUM CHLORIDE. POTASSIUM CHLORIDE 1 20 MEQ, QD U 0 20 MEQ QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126361402 12636140 1 Pulmonary arterial hypertension
126361402 12636140 2 Pulmonary arterial hypertension

Outcome of event

Event ID CASEID OUTC COD
126361402 12636140 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126361402 12636140 Blood sodium decreased
126361402 12636140 Chronic obstructive pulmonary disease
126361402 12636140 Coagulopathy
126361402 12636140 Condition aggravated
126361402 12636140 Constipation
126361402 12636140 Cough
126361402 12636140 Dyspnoea
126361402 12636140 International normalised ratio increased
126361402 12636140 Nausea
126361402 12636140 Paraesthesia
126361402 12636140 Pulmonary fibrosis
126361402 12636140 Renal injury
126361402 12636140 Small intestinal obstruction
126361402 12636140 Sputum discoloured
126361402 12636140 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126361402 12636140 1 20160502 0